Mortality of patients with COPD participating in chronic disease management programmes: a happy end?
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 24718640.
- Also identified by DOI 10.1136/thoraxjnl-2013-204983.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Concerns about increased mortality could question the role of COPD chronic disease management (CDM) programmes. We aimed at extending a recent Cochrane review to assess the effects of CDM on mortality in patients with COPD. Mortality data were available for 25 out of 29 trials identified in a COPD integrated care systematic review. Meta-analysis using random-effects models was performed, followed by subgroup analyses according to study length (3-12 months vs >12 months), main intervention component (exercise, self-management, structured follow-up) and use of an action plan. The meta-analysis showed no impact of CDM on mortality (pooled OR: 1.00, 95% CI 0.79 to 1.28). These results do not suggest that CDM programmes expose patients with COPD to excessive mortality risk.
Medical subject headings
- Disease Management
- Pulmonary Disease, Chronic Obstructive